Clinical Trials on Respiratory Tract Neoplasms in France

Total 18672 results

Steba Biotech S.A.

Terminated

Study Using WST11 in Patients With Obstructing Endobronchial Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

France
Hospices Civils de Lyon

Recruiting

Pleural Carcinomatosis Tissue Banking (TICP)

Pleural Effusion, Malignant

France
University Hospital, Grenoble
Ministry of Health, France

Completed

Pharmacogenomic Study Realized on "Non-small Cell Lung Carcinoma" (Pharmacogenos)

Carcinoma, Non-Small-Cell Lung

France
University Hospital, Lille
INSERM U1189 ONCOTHAI

Recruiting

The IMmunotherapy Pleural 5-ALA PDT (IMPALA)

Malignant Pleural Mesothelioma | Mesotheliomas Pleural

France
Poitiers University Hospital

Active, not recruiting

Radiomics for prEdiction of lunG cAncer biologY

Non Small Cell Lung Cancer | Gene Mutation-Related Cancer | PD-L1 | PET/CT

France
Centre Henri Becquerel

Completed

Study of the Fixation of Various Vectors in PET/CT in Patients With a With Lung Cancer Before and During of CRT or RT (RTEP4)

Carcinoma, Non-Small-Cell Lung | Bronchial Neoplasms

France
Gustave Roussy, Cancer Campus, Grand Paris
Daiichi Sankyo, Inc.

Recruiting

Datopotamab (DS-1062a) in Advanced and/or Unresectable Non-Small Cell Lung Cancer (ICARUS-LUNG01)

Metastatic Lung Cancer

France
Groupe Oncologie Radiotherapie Tete et Cou
Sanofi

Completed

Induction CT by Cisplatin, 5FU With or Without Docetaxel in Patients With T3 and T4 Larynx and Hypopharynx Carcinoma

Larynx Cancer | Hypopharynx Cancer

France
Centre Jean Perrin
Université d'Auvergne; Institut National de Recherche pour l'Agriculture, l... and other collaborators

Recruiting

Microbiota and the Lung Cancer (MICA)

Non Small Cell Lung Cancer

France
University Hospital, Montpellier

Recruiting

Complication and Lung Function Impairment Prediction Using Perfusion and CT Air Trapping (CLIPPCAIR)

Non-small Cell Lung Cancer

France
Hopital Foch

Unknown

Volatil Organic Compounds in Exhaled Air and Sweat After Thoracic Surgery for Carcinological Resection (Onco-VOC)

Lung Cancer, Non-small Cell

France
University Hospital, Montpellier

Completed

Texture Features and PDL1 in CT-PET 18 FDG

Non Small Cell Lung Cancer

France
University of Paris 5 - Rene Descartes

Completed

Hypermetabolism in the Elderly Lung Cancer Patient (HELP)

Non-small Cell Lung Carcinoma

France
Centre Hospitalier Universitaire de Nice

Unknown

The Method ISET (Insulation by Size of Epithelial Tumor Cells)

Non Small Cell Lung Cancer

France
Assistance Publique - Hôpitaux de Paris
National Cancer Institute, France; Recherche Clinique Paris Descartes Necker...

Completed

Truthful Information on Chemotherapy and Its Impact on Chemotherapy at the End of Life (HIPPOCRATE)

Stage IV Lung Cancer

France
Sanofi

Terminated

Safety Study of Docetaxel/Cisplatin Induction Therapy Followed by Concurrent Chemoradiotherapy or Concurrent Chemoradiotherapy Followed by Consolidation Docetaxel/Cisplatin in NSCLC Patients

Non-Small-Cell Lung Carcinoma

France
Sanofi

Completed

Efficacy Study of GEMOX Combination and Vinorelbine in NSCL Patients (GON)

Non Small Cell Lung Cancer

France
Institut Bergonié
Sanofi

Terminated

Concomitant Chemo-radiotherapy in Locally Advanced Non Small Cell Lung Cancer (BIB 01)

Carcinoma, Non-Small-Cell Lung

France
Intergroupe Francophone de Cancerologie Thoracique
Bristol-Myers Squibb; Pierre Fabre Laboratories; Ligue contre le cancer, France

Completed

Chemoradiotherapy of NSCLC Stage IIIB

NSCLC Stage IIIB | Concomitant Radiochemotherapy

France
Assistance Publique - Hôpitaux de Paris

Recruiting

Tumor Rebiopsy During Progression Under Immunotherapy for Patients With Lung Cancer (REBIMMUNE)

Lung Cancer

France
Centre Chirurgical Marie Lannelongue

Active, not recruiting

Epidemiological Study to Assess the Prevalence of Lung Cancer (PREVALUNG)

Lung Cancer | Tobacco | Atherosclerotic Cardiovascular Event

France
University Hospital, Toulouse
Institut National de la Santé Et de la Recherche Médicale, France; National...

Recruiting

Understanding and Overcoming the Early Adaptive Resistance to EGFR Tyrosine-kinase Inhibitors in Lung Cancer Patients (LUNG-RESIST)

Lung Cancer, Nonsmall Cell

France
Institut Bergonié
Groupement Interrégional de Recherche Clinique et d'Innovation

Completed

Immune Mechanisms After Radiofrequency Ablation of Pulmonary Metastases From Colorectal Cancer Origin (ARFIM)

Neoplastic Cells, Circulating | Colo-rectal Cancer | Circulating Tumor Cell | Pulmonary Metastasis | Immune Evasion, Tumor

France
Centre Oscar Lambret

Completed

Pemetrexed, Cisplatin, and Vitamin B12 in Treating Patients With Mesothelioma of the Chest That Cannot Be Removed by Surgery

Malignant Mesothelioma

France
Assistance Publique Hopitaux De Marseille

Active, not recruiting

Precision Immuno-Oncology for Advanced Non-small Cell Lung Cancer Patients With PD-1 ICI Resistance (PIONeeR)

Non-small Cell Lung Cancer

France
Hopital Foch

Terminated

Volatile Organic Compounds in Exhaled Air and Sweat of Patients Treated by Immunotherapy for Lung Cancer: Research on Biomarkers for Early Therapeutic Response (Immuno-VOC)

Lung Cancer, Non-small Cell

France
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Trial of a Vaccination With Tumor Antigen-loaded Dendritic Cell-derived Exosomes (CSET 1437)

Non Small Cell Lung Cancer

France
Centre Oscar Lambret

Completed

Study of the Expression of Met Receptor Fragments in Non Small Cell Lung Cancers (MetLung)

Non Small Cell Lung Cancer

France
University Hospital, Rouen

Completed

Evaluation of Preoperative Endobronchial Ultrasound (EBUS) in Non Small Cell Lung Cancer (NSCLC) (EVIEPEB)

Non Small Cell Lung Cancer

France
University Hospital, Lille
Institut Pasteur de Lille; Institut National de Recherche en Informatique et... and other collaborators

Recruiting

Breath Analysis to Diagnose Lung Cancer (CATOCOV)

Lung Cancer

France
Centre Hospitalier Intercommunal Creteil
University Hospital, Bordeaux; University Hospital, Caen; Rennes University Hospital and other collaborators

Recruiting

Lung Cancer Screening in a Population Exposed to Occupational Lung Carcinogens (LUCSO)

Lung Cancer

France
Centre Henri Becquerel

Recruiting

Dynamics of 18-FDG Uptake in Stage III/IV Non Small Cell Lung Cancer During First Line Pembrolizumab Treatment (iTEP1)

Non Small Cell Lung Cancer

France
Centre Hospitalier Universitaire de Nīmes
MEDEXPRIM; GRATICULE

Completed

Predicting Response to PD-1 Checkpoint Blockade Using Deep Learning Analysis of Imaging and Clinical Data (Onc AI)

Non-small Cell Lung Cancer (NSCLC)

France
Centre Henri Becquerel
Intergroupe Francophone de Cancerologie Thoracique

Unknown

Study of Interest of Personalized Radiotherapy Dose Redistribution in Patients With Stage III NSCLC (RTEP7)

Non-small Cell Lung Cancer

France
Centre Hospitalier Universitaire, Amiens

Unknown

Evaluation of Serum Procalcitonin Rate in Patients With Stage IV Non-small Cell Lung Cancer in First Line Chemotherapy (KBPCT)

Non Small Cells Lung Cancer

France
University Hospital, Bordeaux

Completed

Assessment of 4D 18F-FDG PET-CT in Radiotherapy for Non Small Cell Lung Cancers (PULMOTEP)

Lung Cancer | Non-small-cell Lung Carcinoma

France
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Impact of Surgical Approach on Adaptation of Posture-respiratory Coupling (VaPosVent)

Resectable Lung Non-Small Cell Carcinoma

France
Assistance Publique Hopitaux De Marseille

Terminated

Phase I Multicenter Trial Combining Nivolumab, Ipilimumab and Hypo-fractionated Radiotherapy for Pretreated Advanced Stage Non-small Cell Lung Cancer Patients

Non-small Cell Lung Cancer

France
Poitiers University Hospital
Institut National de la Santé Et de la Recherche Médicale, France

Completed

Prognostic PET/CT Model in Non Small Cell Lung Cancer

Non Small Cell Lung Cancer

France
University Hospital, Strasbourg, France

Completed

Molecular Assessment of Lymph Nodes in Patients With Resected (Stage I to IIIA) Non-small Cell Lung Cancer

Lung Cancer

France
University Hospital, Toulouse

Completed

Rehabilitation by Effort for Patients With Advanced Bronchial Cancer (RehabKBP)

Malignant Mesothelioma | Bronchial Cancer

France
Hôpital Européen Marseille

Completed

Evolution of Corporeal Composition in the PeriOperative Period (ECCOP)

Lung Cancer | Gastrointestinal Cancer (Esophagus, Gastric, Pancreatic, Hepatic, Colorectal and Anal)

France
Institut de Cancérologie de la Loire
Centre Hospitalier Universitaire de Saint Etienne

Unknown

Plan for Systematic Identification of Lung Cancers of Occupational Origin: Implementation Study (RECAP 2)

Broncho Pulmonary Cancer

France
Centre Hospitalier Universitaire de Besancon

Completed

Preliminary Study of Microwave Tumoral Ablation Performances for the Treatment of Pulmonary, Renal and Bone Neoplasia. (TherMO)

Renal Tumor | Bone Tumor | Lung Tumor

France
Institut Curie
Henri Mondor University Hospital

Terminated

Intrapleural Bevacizumab After Pleural Drainage in the Context of Breast Cancer (BEVAP)

Breast Cancer | Pleural Effusion, Malignant

France
University Hospital, Toulouse

Recruiting

A Machine Learning Approach to Identify Patients With Resected Non-small-cell Lung Cancer With High Risk of Relapse (MIRACLE)

Non-small Cell Lung Cancer Stage IIIA

France
Groupe Oncologie Radiotherapie Tete et Cou
National Cancer Institute, France

Recruiting

Chemo-radiotherapy Versus Radiotherapy in the Treatment of Salivary Glands and Nasal Tumors (IMRT or Protontherapy) (SANTAL)

HNSCC

France
Assistance Publique - Hôpitaux de Paris
Commissariat A L'energie Atomique

Not yet recruiting

Personalized Estimation of Doses Delivered During Image Guided Radiation Therapy Tests (ELISA)

Breast Cancer | Lung Neoplasm | Cancer Pediatric | Pelvic Neoplasm | Cancer, Otorhinolaryngeal

France
Hospices Civils de Lyon

Unknown

Association of Bone and Metabolic Parameters With Overall Survival in Patients With Bone Metastases From Adenocarcinoma Lung Cancer (POUMOS) (POUMOS)

Lung Cancer | Bone Metastases

France
Centre Hospitalier Universitaire Dijon

Not yet recruiting

Pilot Study of the Contribution of Fractional Exhaled Nitric Oxide as a Prognostic Marker of Response to Anti-PD-L1 Immunotherapy in Non-small Cell Lung Cancer (FENOTYPE)

Metastatic Non-small Cell Lung Cancer

France

Clinical Trials on Respiratory Tract Neoplasms in France

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Equatorial Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations